Search In this Thesis
   Search In this Thesis  
العنوان
Release of Piroxicam Form Semisolid Dosage Forms /
الناشر
Usama Farghaly Aly Hassan,
المؤلف
Hassan, Usama Farghaly Aly.
هيئة الاعداد
باحث / Usama Farghaly Aly Hassan
مشرف / Sayed Ismail Mohamed
مشرف / Mohamed Gamal Abd El-Mohsen
مشرف / Gamal Abd El-Fattah
الموضوع
Pharmaceutics. Piroxicam. Semisolid Dosage Forms.
تاريخ النشر
2002 .
عدد الصفحات
206 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الصيدلة ، علم السموم والصيدلانيات (المتنوعة)
تاريخ الإجازة
1/1/2002
مكان الإجازة
جامعة المنيا - كلية الصيدلة - الصيدلانيات
الفهرس
Only 14 pages are availabe for public view

from 234

from 234

Abstract

Piroxicam is one of the most potent non-steroidal antiinflammatory agents, which also exhibits antipyretic activity. it is used as an effective analgesic and antiinflammatory agent in rheumatoid arthitis, osteoarthritis, ankylosing spondylitis , and acute musculoskeletal disorders. Although the usual oral dose of PXM is well tolerated by the patients, yet several side effects have been reported including gastrointestinal disturbamce.in addation , peptic ulcer has been reported in about 9% of the patients with chronic arthritis when treated with 20mg of daily oral dose. Patient compliance is also a common therapeutic problem in the management of chronic inflammatory diseases because most NSAIDs must be administered in multiple daily dose to maintain therapeutic blood level.